Special Issue "Paediatric Dosage Forms: New Approaches to Old Challenges"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".
Deadline for manuscript submissions: closed (20 May 2023) | Viewed by 786
Special Issue Editors
Interests: paediatric formulations; extemporaneous compounding; medicines for children
Interests: pharmaceutics; formulation; patient centric; children; acceptability; palatability; taste masking
Special Issue Information
Dear Colleagues,
The paediatric population ranges from neonates to adolescents, with distinct differences in size, body composition, bodily function and sensory maturity across this age range. Many medicines for adults have potential applications for children but lack the dosing flexibility and demonstration of safety and efficacy through clinical trials to support use across the paediatric spectrum. Young children, especially neonates, handle drugs and excipients differently to older children and adults. With this in mind, a range of methods have been investigated to develop suitable patient-centric paediatric formulations.
The aim of this Special Issue of Pharmaceutics is to highlight new methodology related to paediatric product research and development. We invite researchers to publish their original research or review articles regarding the reformulation of off-patent drugs, novel excipients, administration devices and sensory pharmaceutics, with a focus on paediatrics.
Dr. Sara Hanning
Prof. Dr. Catherine Tuleu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- paediatric/pediatric
- neonate
- off-patent reformulation
- novel excipients
- administration devices
- sensory pharmaceutics
- paediatric product research and development
